相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2021)
The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis
Reza Sari Motlagh et al.
JOURNAL OF UROLOGY (2021)
Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
Barbara Bressi et al.
SUPPORTIVE CARE IN CANCER (2021)
Risk of dementia following androgen deprivation therapy for treatment of prostate cancer
Anna Krasnova et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Concurrent benzodiazepine use in older adults treated with antidepressants in Asia
Xiao-Mei Zhong et al.
INTERNATIONAL PSYCHOGERIATRICS (2019)
Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database
Bum Sik Tae et al.
CANCER RESEARCH AND TREATMENT (2019)
Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases
Jui-Ming Liu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
Trazodone use and risk of dementia: A population-based cohort study
Ruth Brauer et al.
PLOS MEDICINE (2019)
Taiwan's National Health Insurance Research Database: past and future
Cheng-Yang Hsieh et al.
CLINICAL EPIDEMIOLOGY (2019)
Androgen deprivation therapy for prostate cancer and risk of dementia
David Robinson et al.
BJU INTERNATIONAL (2019)
Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer
Ravishankar Jayadevappa et al.
JAMA NETWORK OPEN (2019)
Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study
Huah Shin Ng et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy
Rishi Deka et al.
JAMA ONCOLOGY (2018)
Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer
Seo Hyon Baik et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer
Farzin Khosrow-Khavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis
K. T. Nead et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Association Between Androgen Deprivation Therapy and Risk of Dementia
Kevin T. Nead et al.
JAMA ONCOLOGY (2017)
No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study
Li-Ting Kao et al.
ASIAN JOURNAL OF ANDROLOGY (2017)
Hormone therapy for prostate cancer increases the risk of Alzheimer's disease: a nationwide 4-year longitudinal cohort study
Jhen-Hao Jhan et al.
AGING MALE (2017)
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Peter C. Austin et al.
CIRCULATION (2016)
Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
Xiaojuan Mi et al.
STATISTICS IN MEDICINE (2016)
Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer
S. D. Chung et al.
ANDROLOGY (2016)
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
C. Parker et al.
ANNALS OF ONCOLOGY (2015)
Reflections On The 20th Anniversary Of Taiwan's Single-Payer National Health Insurance System
Tsung-Mei Cheng
HEALTH AFFAIRS (2015)
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Emily Herrett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Effectiveness of Androgen-Deprivation Therapy and Radiotherapy for Older Men With Locally Advanced Prostate Cancer
Justin E. Bekelman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database
Caroline Fairhurst et al.
BMJ OPEN (2014)
The Epidemiology of Depression Across Cultures
Ronald C. Kessler et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)
Propensity Score Methods for Confounding Control in Nonexperimental Research
M. Alan Brookhart et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Gender, sex steroid hormones, and Alzheimer's disease
Rebekah S. Vest et al.
HORMONES AND BEHAVIOR (2013)
Testosterone levels and cognition in elderly men: A review
J. Holland et al.
MATURITAS (2011)
Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association Endorsed by the American Society for Radiation Oncology
Glenn N. Levine et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Effectiveness of androgen deprivation therapy in prolonging survival of older men treated for locoregional prostate cancer
L. Holmes et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
The association between endogenous free testosterone and cognitive performance: A population-based study in 35 to 90 year-old men and women
Petra P. Thilers et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Age-related testosterone depletion and the development of Alzheimer disease
ER Rosario et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Trazodone for erectile dysfunction: a systematic review and meta-analysis
HA Fink et al.
BJU INTERNATIONAL (2003)
Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men
SD Moffat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
分享论文
